Agreed Welsh. I've long said that it is well undervalued. The SP really only reflects the cash in the bank. Their IP and even their sales of actual product are not valued at all. I think it is partly a function of being so small they drop off the radar of the bigger firms, and also because Biotech is not really valued in Australia. I've long said it should currently be approx 20 - 30, with plenty of upside from that price once the Stage 3 or US defence forces finalise their testing.
IMC Price at posting:
10.5¢ Sentiment: Buy Disclosure: Held
